Mumbai's civic hospitals begin use of Tocilizumab in severe coronavirus cases; 30 of 40 patients show drastic improvement
Multiple hospitals which come under the BMC have started using a new drug to treat patients who have been severely affected due to COVID-19
Mumbai: Multiple hospitals which come under the Brihanmumbai Municipal Corporation (BMC) have started using a new drug to treat patients who have been severely affected due to COVID-19.
BMC medical college hospitals, Sion, Nair, KEM and Seven Hills have started using the Tocilizumab injection, according to a release by the municipal corporation.
So far the drug has been used on approximately 40 COVID-19 patients, who were severely affected, and encouraging results have been seen in more than 30 patients, with 14 patients having already recovered and discharged from the hospital, according to BMC.
This medicine has improved the condition of the patients and has prevented patients from being put on ventilators and hastened their recovery.
The drug, Tocilizumab, has been used based on the experiences of many physicians and hospitals world over. Out of three patients from Dharavi, who have been administered this drug, one male patient aged 38 years was discharged from Nair Hospital on Tuesday.
Maharashtra with 23,401 confirmed COVID-19 cases is the worst-affected state by the infection in the country. However, 4,786 patients have also been cured and discharged as of Tuesday morning, according to the Ministry of Health and Family Welfare.
India logs 17,336 new COVID-19 cases in last 24 hours, up 30% from yesterday; positivity rate jumps to 4.32%
Delhi and Maharashtra reported the maximum number of COVID-19 cases in the last 24 hours. As many as 13 people died of COVID-19, increasing the cumulative casualty due to the virus in the country to 5,24,954
The 81-year-old Fauci, who is fully vaccinated and has received two booster shots, was experiencing mild COVID-19 symptoms. He tested positive on a rapid antigen test
Delhi on Monday reported 614 new COVID-19 cases and zero death due to the disease, while the positivity rate stood at 7.06 per cent